NeuroRPM News Center

Press Releases

NeuroRPM Becomes an athenahealth Solution Partner, Now Available in the athenahealth Marketplace

October 6, 2026

Bringing reimbursable, continuous Parkinson’s monitoring into clinical workflows.

Button

NeuroRPM to Deploy AI-Enabled Digital Biomarker Monitoring for Annovis Bio’s Parkinson’s Disease Clinical Trial

March 19, 2026

NeuroRPM supports Annovis Bio’s Parkinson’s clinical trial with continuous, real-world motor symptom monitoring.

Button

NeuroRPM Announces FDA Clearance for AI-Powered Parkinson’s Monitoring on Apple Watch

March 23, 2023

NeuroRPM Receives FDA Clearance as the First FDA-Cleared, AI-Enabled Digital Biomarker Platform for Continuous, Real-World Measurement of Parkinson’s Motor Symptoms.

Button

NeuroRPM in the News

Annovis Bio turns to NeuroRPM to study its Parkinson’s drug

March 19, 2026

STAT examines how Annovis Bio is using NeuroRPM and Apple Watch to collect objective motor data in its Parkinson’s clinical trial.

STAT+ subscription may be required.

NeuroRPM helps bring Apple Watch-based Parkinson’s monitoring into everyday care

October 24, 2023

STAT examines how NeuroRPM and other Apple Watch-based technologies are advancing continuous Parkinson’s symptom monitoring outside the clinic.

STAT+ subscription may be required.

FDA clears NeuroRPM Apple Watch app to monitor daily Parkinson’s symptoms

March 27, 2023

Parkinson’s News Today covers NeuroRPM’s FDA clearance and its use of Apple Watch and AI to continuously monitor Parkinson’s motor symptoms in daily life.